Evidence map›Paper›PMID 41269362›Full record

ArticleClinical oral investigations2025

Risk factors and outcomes of consecutive dental implant replacements at failed sites: a retrospective cohort study.

Ceylan Güzel, Sümer Münevveroğlu, Berk Beşkardeş, Mustafa Temiz

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical oral investigations, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ceylan GüzelDepartment of Oral and Maxillofacial Surgery, Faculty of Dentistry, Istanbul Medipol University, İstanbul, Turkey. ceylan.guzel@medipol.edu.tr.
Sümer MünevveroğluDepartment of Oral and Maxillofacial Surgery, Faculty of Dentistry, Istanbul Medipol University, İstanbul, Turkey.
Berk BeşkardeşDepartment of Oral and Maxillofacial Surgery, Faculty of Dentistry, Graduate School of Health Sciences, Istanbul Medipol University, İstanbul, Turkey.
Mustafa TemizDepartment of Oral and Maxillofacial Surgery, Faculty of Dentistry, Istanbul Medipol University, İstanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundReimplantation of dental implants at sites of prior failure remains a clinical challenge with variably reported success rates. This retrospective study evaluated the clinical outcomes of consecutive implant reimplantations at previously failed sites and analyzed associated risk factors for re-failure.

methodsRecords of 5,201 dental implants placed from 2017 to 2021 were reviewed. A total of 203 implants failed (initial failure rate 3.9%), and 189 of these sites underwent reimplantation. Clinical variables included age, gender, smoking, hypertension, diabetes mellitus, antithrombotic medication use (particularly ASA), bone grafting, implant location, timing of failure, and patient willingness to continue treatment. Statistical analyses included chi-square and Fisher's exact tests for group comparisons, independent-samples t-tests for continuous variables, and univariate logistic regression for risk factor assessment. Analyses were descriptive and based on proportions and univariate logistic regression; time-to-event methods were not applied, and results should be interpreted as exploratory.

resultsSurvival was 96.1% for initial implants (4,998/5,201), 78.8% (149/189) for first reimplantations, and 51.5% (17/33) for second reimplantations (χ² for trend, p < 0.001). Older patient age was significantly associated with failure across all stages. Hypertension (7.1% vs. 2.6%; p < 0.001) and diabetes mellitus (8.2% vs. 2.8%; p < 0.001) were significantly associated with initial implant failure but not with reimplantation outcomes. Prior bone grafting increased failure risk during initial placement (7.2% vs. 3.4%; p < 0.001) but showed no significant effect in reimplantations. ASA use significantly reduced the risk of failure during the first reimplantation (OR = 0.42; 95% CI: 0.21-0.87; p = 0.020). Smoking and implant location (mandible vs. maxilla) were not statistically significant predictors at any stage. Patient willingness to undergo further treatment declined after consecutive failures (93.1% after initial failure vs. 82.5% after second failure; χ²=3.51, p = 0.061; Fisher p = 0.057).

conclusionsImplant survival decreased with each reimplantation attempt, with markedly reduced outcomes in the second reimplantation cohort. Older age, diabetes, hypertension, and prior grafting were associated with initial failure, whereas ASA use appeared protective during first reimplantation. Given the descriptive and unadjusted nature of our analyses, these findings should be viewed as hypothesis-generating and require confirmation in prospective, multicenter studies using time-to-event and adjusted models.

Indexed as

Dental Implantation, EndosseousDental ImplantsDental Restoration FailureAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedReoperationRetrospective StudiesRisk FactorsTreatment OutcomeDental ImplantsDental implant failureReimplantationRisk factors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.